Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023. Lilly ...

Up to 3.4 million eligible patients could benefit from the medication that treats type 2 diabetes and aids weight loss ...

When Henry Conway hit his forties his BMI became dangerously high. After a lover said ‘I love your little dad bod’, he knew ...

If you're looking for a tool to help you take control of your weight and overall health, the Mounjaro pen represents a promising option that addresses both the physical and hormonal factors that make ...

Treatment with Zepbound, whose generic name is tirzepatide, led to improvements in both sets of patients, according to results published in June in the New England Journal of Medicine. The trials ...